ArticleThe Journal of international medical research2024

Case report: targeted therapy of malignant pleural mesothelioma with anaplastic lymphoma kinase receptor tyrosine kinase gene fusion mutation by crizotinib.

Yufeng Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.